Talis Biomedical Corp
NASDAQ:TLIS
Income Statement
Earnings Waterfall
Talis Biomedical Corp
Revenue
|
2.2m
USD
|
Cost of Revenue
|
-2.4m
USD
|
Gross Profit
|
-176k
USD
|
Operating Expenses
|
-77.5m
USD
|
Operating Income
|
-77.7m
USD
|
Other Expenses
|
2.2m
USD
|
Net Income
|
-75.5m
USD
|
Income Statement
Talis Biomedical Corp
Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
12
N/A
|
11
-10%
|
18
+60%
|
17
-4%
|
8
-55%
|
8
+8%
|
4
-46%
|
5
+10%
|
5
+12%
|
5
-11%
|
3
-41%
|
3
+0%
|
2
-23%
|
|
Gross Profit | ||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(5)
|
(6)
|
(8)
|
(5)
|
(4)
|
(2)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(1)
-221%
|
(2)
-42%
|
(4)
-139%
|
(2)
+43%
|
(1)
+63%
|
(0)
+77%
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(66)
|
(102)
|
(162)
|
(215)
|
(215)
|
(200)
|
(165)
|
(127)
|
(115)
|
(112)
|
(99)
|
(90)
|
(78)
|
|
Selling, General & Administrative |
(10)
|
(13)
|
(18)
|
(26)
|
(35)
|
(42)
|
(47)
|
(46)
|
(42)
|
(41)
|
(35)
|
(32)
|
(30)
|
|
Research & Development |
(57)
|
(89)
|
(143)
|
(190)
|
(180)
|
(158)
|
(118)
|
(81)
|
(73)
|
(71)
|
(64)
|
(57)
|
(48)
|
|
Operating Income |
(54)
N/A
|
(91)
-68%
|
(144)
-58%
|
(199)
-38%
|
(207)
-4%
|
(192)
+8%
|
(164)
+14%
|
(127)
+23%
|
(116)
+9%
|
(115)
+0%
|
(101)
+12%
|
(90)
+11%
|
(78)
+14%
|
|
Pre-Tax Income | ||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
|
Total Other Income |
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
1
|
2
|
3
|
4
|
5
|
|
Pre-Tax Income |
(55)
N/A
|
(91)
-67%
|
(144)
-58%
|
(199)
-38%
|
(208)
-4%
|
(192)
+7%
|
(165)
+14%
|
(127)
+23%
|
(115)
+10%
|
(113)
+1%
|
(98)
+13%
|
(86)
+12%
|
(75)
+12%
|
|
Net Income | ||||||||||||||
Income from Continuing Operations |
(55)
|
(91)
|
(144)
|
(199)
|
(208)
|
(192)
|
(165)
|
(127)
|
(115)
|
(113)
|
(98)
|
(86)
|
(75)
|
|
Net Income (Common) |
(1)
N/A
|
(91)
-12 735%
|
(144)
-58%
|
(199)
-38%
|
(208)
-4%
|
(192)
+7%
|
(165)
+14%
|
(127)
+23%
|
(115)
+10%
|
(113)
+1%
|
(98)
+13%
|
(86)
+12%
|
(75)
+12%
|
|
EPS (Diluted) |
-0.45
N/A
|
-58.04
-12 798%
|
-84.35
-45%
|
-116.18
-38%
|
-120.68
-4%
|
-127.17
-5%
|
-93.51
+26%
|
-71.82
+23%
|
-64.45
+10%
|
-63.48
+2%
|
-54.63
+14%
|
-47.14
+14%
|
-41.48
+12%
|